Subtype
Functioning Pancreatic Neuroendocrine Tumor
CI-CAN-00000896Explore in graph →
Non-malignant4 active trials
- NCIt
- C45840
Loading cancer entity…
Subtype
CI-CAN-00000896Explore in graph →
Clinical trials
42 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00001276 | Diagnosing and Treating Low Blood Sugar Levels | recruiting | — | 1,500 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Sep 28, 2026 | clinicaltrials |
| NCT07808879 | Comparison of [68Ga]Ga-HBED-CC-PEG6-Exendin-4 and [68Ga]Ga-HBED-CC-Exendin-4 PET/CT for Insulinoma Localization(HBED-CC-PEG6-E) | recruiting | N/A | 20 | Peking Union Medical College HospitalOTHER | 1 |
| Sep 9, 2026 |
| clinicaltrials |
| NCT06725693 | Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease | recruiting | — | 500 | Tianjin Medical UniversityOTHER | 1 | Sep 8, 2026 | clinicaltrials |
| NCT02021604 | Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma | recruiting | Phase 1 | 250 | Cook Children's Health Care SystemOTHER | 1 | Jul 16, 2024 | clinicaltrials |
Data updated 2 days agoSource updated Sep 28, 2026source: clinicaltrials